| Safety and antitumor activity of recombinant soluble Apo2 ligand A Ashkenazi, RC Pai, S Fong, S Leung, DA Lawrence, SA Marsters, ... The Journal of clinical investigation 104 (2), 155-162, 1999 | 2877 | 1999 |
| Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family RM Pitti, SA Marsters, S Ruppert, CJ Donahue, A Moore, A Ashkenazi Journal of Biological Chemistry 271 (22), 12687-12690, 1996 | 2518 | 1996 |
| Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors JP Sheridan, SA Marsters, RM Pitti, A Gurney, M Skubatch, D Baldwin, ... Science 277 (5327), 818-821, 1997 | 2272 | 1997 |
| Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer RM Pitti, SA Marsters, DA Lawrence, M Roy, FC Kischkel, P Dowd, ... Nature 396 (6712), 699-703, 1998 | 1151 | 1998 |
| Designing CD4 immunoadhesins for AIDS therapy DJ Capon, SM Chamow, J Mordenti, SA Marsters, T Gregory, H Mitsuya, ... Nature 337 (6207), 525-531, 1989 | 934 | 1989 |
| A novel receptor for Apo2L/TRAIL contains a truncated death domain SA Marsters, JP Sheridan, RM Pitti, A Huang, M Skubatch, D Baldwin, ... Current Biology 7 (12), 1003-1006, 1997 | 912 | 1997 |
| Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions D Lawrence, Z Shahrokh, S Marsters, K Achilles, D Shih, B Mounho, ... Nature medicine 7 (4), 383-385, 2001 | 902 | 2001 |
| Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. S Shak, DJ Capon, R Hellmiss, SA Marsters, CL Baker Proceedings of the National Academy of Sciences 87 (23), 9188-9192, 1990 | 885 | 1990 |
| Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen DH Smith, RA Byrn, SA Marsters, T Gregory, JE Groopman, DJ Capon Science 238 (4834), 1704-1707, 1987 | 674 | 1987 |
| Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis M Lu, DA Lawrence, S Marsters, D Acosta-Alvear, P Kimmig, AS Mendez, ... science 345 (6192), 98-101, 2014 | 590 | 2014 |
| Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer C Montagut, A Dalmases, B Bellosillo, M Crespo, S Pairet, M Iglesias, ... Nature medicine 18 (2), 221-223, 2012 | 540 | 2012 |
| Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. A Ashkenazi, SA Marsters, DJ Capon, SM Chamow, IS Figari, D Pennica, ... Proceedings of the National Academy of Sciences 88 (23), 10535-10539, 1991 | 480 | 1991 |
| Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI SA Marsters, M Yan, RM Pitti, PE Haas, VM Dixit, A Ashkenazi Current Biology 10 (13), 785-788, 2000 | 464 | 2000 |
| Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the … SA Marsters, TM Ayres, M Skubatch, CL Gray, M Rothe, A Ashkenazi Journal of Biological Chemistry 272 (22), 14029-14032, 1997 | 357 | 1997 |
| Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB SA Marsters, JP Sheridan, CJ Donahue, RM Pitti, CL Gray, AD Goddard, ... Current Biology 6 (12), 1669-1676, 1996 | 356 | 1996 |
| An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells NS Wilson, B Yang, A Yang, S Loeser, S Marsters, D Lawrence, Y Li, ... Cancer cell 19 (1), 101-113, 2011 | 340 | 2011 |
| A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors D Oksenberg, SA Marsters, BF O'Dowd, H Jin, S Havlik, SJ Peroutka, ... Nature 360 (6400), 161-163, 1992 | 329 | 1992 |
| Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. A Ashkenazi, LG Presta, SA Marsters, TR Camerato, KA Rosenthal, ... Proceedings of the National Academy of Sciences 87 (18), 7150-7154, 1990 | 311 | 1990 |
| Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity M Yan, SA Marsters, IS Grewal, H Wang, A Ashkenazi, VM Dixit Nature immunology 1 (1), 37-41, 2000 | 298 | 2000 |
| Antibody-based targeting of FGFR3 in bladder carcinoma and t (4; 14)-positive multiple myeloma in mice J Qing, X Du, Y Chen, P Chan, H Li, P Wu, S Marsters, S Stawicki, J Tien, ... The Journal of clinical investigation 119 (5), 1216-1229, 2009 | 295 | 2009 |
